PARADIGM BIOPHARMACEUTICALS

paradigm-biopharmaceuticals-logo

They focus on repurposing pentosan polysulphate sodium (PPS) for new orthopaedic and respiratory applications. They address conditions that start with and are sustained by inflammation. Lead clinical indications involve treating injury that results in bone marrow edema (BME) and the allergic inflammatory response in allergic rhinitis (AR), which is commonly known as โ€˜Hay Feverโ€™.

#SimilarOrganizations #People #Website #More

PARADIGM BIOPHARMACEUTICALS

Industry:
Biotechnology Health Care Medical

Address:
Melbourne, Victoria, Australia

Country:
Australia

Website Url:
http://www.paradigmbiopharma.com

Total Employee:
51+

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome


Similar Organizations

tienland-logo

TiENLAND

Australian Pharmaceutical Health Products

Current Employees Featured

jeannie-joughin_image

Jeannie Joughin
Jeannie Joughin Chief Operating Officer @ Paradigm Biopharmaceuticals
Chief Operating Officer
2020-06-01

Stock Details


Company's stock symbol is ASX:PAR

Official Site Inspections

http://www.paradigmbiopharma.com Semrush global rank: 4.78 M Semrush visits lastest month: 1.92 K

  • Host name: server-3-171-38-52.iad61.r.cloudfront.net
  • IP address: 3.171.38.52
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Paradigm Biopharmaceuticals"

About - Paradigm Biopharmaceuticals

Paradigm Biopharmaceuticals (Paradigm, ASX:PAR) is a commercially-focused drug development company. We believe identifying and transforming underutilised molecules is the most optimal path to addressing an unmet โ€ฆSee details»

Contact - Paradigm Biopharmaceuticals

Investor EnquirySee details»

PARADIGM PHARMA INC.

Paradigm Pharma : Prevention to Treatment Paradigm Pharma, a U.S. company, markets and sells a wide range of pharmaceuticals as well as complementary nutraceuticals. Its โ€ฆSee details»

Paradigm Biopharmaceuticals (PBIGF) Company Profile

Apr 9, 2025 Company profile for Paradigm Biopharmaceuticals Limited (PBIGF) with a description, list of executives, contact details and other key facts.See details»

Paradigm Biopharmaceuticals Company Profile | Management and โ€ฆ

Find contact information for Paradigm Biopharmaceuticals. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Paradigm Biopharmaceuticals's email format.See details»

Paradigm Biopharmaceuticals Management Team | Org Chart

Paradigm Biopharmaceuticals employs 22 employees. The Paradigm Biopharmaceuticals management team includes Paul Rennie (Managing Director), Beverley Huttmann (Head of โ€ฆSee details»

Paradigm BioCapital Advisors LP

Investing in Transformative TherapeuticsParadigm BioCapital Advisors LP | 767 Third Avenue, 17th Floor | New York, NY 10017See details»

Org Chart Paradigm Biopharma - The Official Board

The org chart of Paradigm Biopharma contains its 6 main executives including Paul Rennie and Simon White.See details»

Paradigm Biopharmaceuticals - Crunchbase Company Profile

Paradigm is a global biopharmaceutical company driven to discover to improve patientsโ€™ health and quality of lifeSee details»

Paradigm Biopharma 2025 Company Profile: Stock โ€ฆ

Information on stock, financials, earnings, subsidiaries, investors, and executives for Paradigm Biopharma. Use the PitchBook Platform to explore the full profile.See details»

Paradigm Biopharmaceuticals Information - RocketReach

Paradigm Biopharmaceuticals is a Pharmaceutical Manufacturing, Manufacturing General, and Biotechnology company located in Melbourne, Victoria with $8.4 million in revenue and 23 โ€ฆSee details»

PAR News, Analysis, Announcements & Results | Paradigm ...

2 days ago The latest Paradigm Biopharmaceuticals Limited [PAR] news, articles, data and analysis from The Australian Financial ReviewSee details»

Paradigm Biopharmaceuticals Company Profile - Craft

Oct 4, 2024 Paradigm Biopharmaceuticals $66 k in annual revenue in FY 2024. See insights on Paradigm Biopharmaceuticals including office locations, competitors, revenue, financials, โ€ฆSee details»

Paradigm Biopharma - The Org

Paradigm Biopharma (PAR) listed on the ASX in August 2015. Paradigm Biopharma's focus is on repurposing pentosan polysulphate sodium (PPS) for the treatment of diseases sustained by โ€ฆSee details»

Paradigm Biopharma's Leadership Team - The Org

Paradigm Biopharma's Leadership Team includes Paul Rennie and 6 others.See details»

Executive Team - Paradigm Biopharmaceuticals

Paradigmโ€™s leadership team is highly experienced in scientific discovery, regulatory affairs, drug development, clinical trials, finance, and investor relations, as well as licensing and โ€ฆSee details»

Paradigm Biopharmaceuticals

Feb 25, 2025 Paradigm Biopharmaceuticals was founded in 2000 by a group of scientists and researchers who wanted to take on the challenge of developing new and innovative drugs. โ€ฆSee details»

Paradigm Biopharmaceuticals - Overview, News & Similar

Nov 22, 2023 View Paradigm Biopharmaceuticals (www.paradigmbiopharma.com) location in Victoria, Australia , revenue, industry and description. Find related and similar companies as โ€ฆSee details»

Paradigm Biopharmaceuticals Overview | SignalHire Company Profile

Paradigm Biopharmaceuticals is a private company that has been in the industry for 9 years. The company currently specializes in the Pharmaceuticals area. Its headquarters is located at โ€ฆSee details»

Paradigm Biopharmaceuticals CEO and Key Executive Team

Paradigm Biopharmaceuticals's Executive Chairman and CEO is Paul Rennie. Other executives include Ravi Krishnan, Chief Scientific Officer; Melanie Duiker, Clinical Operations Director โ€ฆSee details»

linkstock.net © 2022. All rights reserved